Financial results - ORIGO PHARMA S.R.L.

Financial Summary - Origo Pharma S.r.l.
Unique identification code: 26805900
Registration number: J12/635/2010
Nace: 4690
Sales - Ron
-
Net Profit - Ron
Employee
The most important financial indicators for the company Origo Pharma S.r.l. - Unique Identification Number 26805900: sales in 2022 was - euro, registering a net profit of euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata nespecializat having the NACE code 4690.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Origo Pharma S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 67.050 83.927 112.117 99.963 26.407 0 0 0 0 -
Total Income - EUR 67.077 84.863 112.453 101.877 26.435 172 0 0 0 -
Total Expenses - EUR 70.331 73.319 91.433 99.781 33.806 3.297 0 0 0 -
Gross Profit/Loss - EUR -3.254 11.545 21.020 2.096 -7.371 -3.126 0 0 0 -
Net Profit/Loss - EUR -3.254 11.545 19.356 864 -7.636 -3.131 0 0 0 -
Employees 3 3 2 2 0 0 0 0 0 -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Origo Pharma S.r.l.

Rating financiar

Financial Rating -
Origo Pharma S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Origo Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Origo Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Origo Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Origo Pharma S.r.l. - CUI 26805900

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 2.519 1.881 1.209 8.032 0 0 0 0 0 -
Current Assets 38.778 32.775 20.074 17.797 3.472 169 166 162 163 -
Inventories 10.470 21.173 7.593 10.337 241 0 0 0 0 -
Receivables 27.442 9.985 9.239 6.149 251 166 163 159 160 -
Cash 866 1.616 3.242 1.311 2.980 3 3 3 3 -
Shareholders Funds -24.590 -13.250 6.241 6.999 -765 -3.881 -3.807 -3.723 -3.735 -
Social Capital 223 225 223 219 215 211 207 202 203 -
Debts 65.887 47.906 15.043 18.830 4.237 4.050 3.973 3.885 3.897 -
Income in Advance 0 0 0 0 0 0 0 0 0 -
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4690 - 4690"
CAEN Financial Year 4690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 163 euro in 2022 which includes Inventories of 0 euro, Receivables of 160 euro and cash availability of 3 euro.
The company's Equity was valued at -3.735 euro, while total Liabilities amounted to 3.897 euro.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Origo Pharma S.r.l.

Comments - Origo Pharma S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.